Cargando…
PPRX-1701, a nanoparticle formulation of 6′-bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models
Derivatives of the Chinese traditional medicine indirubin have shown potential for the treatment of cancer through a range of mechanisms. This study investigates the impact of 6′-bromoindirubin-3′-acetoxime (BiA) on immunosuppressive mechanisms in glioblastoma (GBM) and evaluates the efficacy of a B...
Autores principales: | Zdioruk, Mykola, Jimenez-Macias, Jorge-Luis, Nowicki, Michal Oskar, Manz, Katherine E., Pennell, Kurt D., Koch, Marilin S., Finkelberg, Tomer, Wu, Bin, Boucher, Paul, Takeda, Yuji, Li, Weiyi, Piranlioglu, Raziye, Ling, Alexander L., Chiocca, E. Antonio, Lawler, Sean E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213750/ https://www.ncbi.nlm.nih.gov/pubmed/37060903 http://dx.doi.org/10.1016/j.xcrm.2023.101019 |
Ejemplares similares
-
Uncovering transcriptomic landscape alterations of CAN-2409 in in vitro and in vivo glioma models
por: Koch, Marilin S., et al.
Publicado: (2023) -
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models
por: Koch, Marilin S, et al.
Publicado: (2022) -
HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials
por: Koch, Marilin S., et al.
Publicado: (2020) -
Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma
por: Koch, Marilin S., et al.
Publicado: (2022) -
Crespones y campanas tlaxcaltecas en 1701 /
por: González Acosta, Alejandro
Publicado: (2000)